IBBQ

Invesco Nasdaq Biotechnology ETF [IBBQ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

IBBQ Stock Summary

Top IBBQ Correlated Resources

IBBQ

Top 10 Correlated ETFs

IBBQ

Top 10 Correlated Stocks

IBBQ

In the News

IBBQ Financial details

Company Rating
-
Market Cap
29.12M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.04
Dividend %
0.78%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-9.09%
SMA50
-13.04%
SMA100
-9.09%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
18.18-23.02
52W High
-14.43%
52W Low
+9.33%
RSI
43
Rel Volume
0.18
Avg Volume
19.51K
Volume
3.57K
Perf Week
4.46%
Perf Month
-12.06%
Perf Quarter
-16.18%
Perf Half Y
-18.34%
-
-
-
-
Beta
0.650014
-
-
Volatility
0.2%, 1.24%
Prev Close
-0.71%
Price
19.68
Change
4.46%

IBBQ Financial Performance

IBBQ Dividend History

IBBQ Frequently Asked Questions

What is Invesco Nasdaq Biotechnology ETF stock symbol ?

Invesco Nasdaq Biotechnology ETF is a US stock and trading under the symbol IBBQ

What is Invesco Nasdaq Biotechnology ETF stock quote today ?

Invesco Nasdaq Biotechnology ETF stock price is $19.68 today.

Is Invesco Nasdaq Biotechnology ETF stock public?

Yes, Invesco Nasdaq Biotechnology ETF is a publicly traded company.

Something similar

Top by Market Cap
ABEC.DE
BRH.DE
VTI
LLY
VTSAX
Top Correlated ETFs
XBI
IBB
BIB
IDNA
IBRN
Top Correlated Stocks
FBIOX
TMO
BHVN
DYN
CDZI
Similar Market Cap
OTMO
MWB.DE
1241.HK
AYIMA-B.ST
0UXL.L

Company Profile

Financial Services Asset Management
  • Volume Average 19.51K
  • Market Capitalization 29.12M
  • Headquarters US
  • IPO Date 2021-06-11

The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.